Nasdaq · CIK 0001668397 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Medpace Holdings, Inc.
MEDP chart by TradingView
PRICE HISTORY
LIVE · NASDAQMEDP chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $2.5B
- EBITDA
- $0.6B
- FREE CASH FLOW
- $0.7B
- EPS
- $15.28
- GROSS MARGIN
- —
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
30.8x
-64%21.9x101.1x
⤢
P / SALES (TTM)
5.4x
+96%2.6x7.1x
⤢
P / BOOK
34.9x
+1794%1.8x53.1x
⤢
EV / EBITDA (TTM)
—
+32%11.7x18.3x
⤢
EV / REVENUE (TTM)
—
-4%2.9x3.7x
⤢
FCF YIELD (TTM)
4.67%
-1.1pp2.88%8.65%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$0.7B
+556%⤢
EBITDA (DERIVED)
$0.2B
+464%⤢
NET INCOME
$0.1B
+2310%⤢
EPS (DILUTED)
$4.25
+3075%⤢
REVENUE GROWTH YOY
17.24%
+10.2pp-4.25%70.49%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
19.52%
-17.6pp-4.74%37.63%
⤢
RETURN ON CAPITAL
—
+10.2pp1.77%12.02%
⤢
RETURN ON EQUITY (TTM)
113.29%
+111.1pp2.18%242.70%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN—
OPERATING MARGIN20.76%
NET MARGIN17.16%
FCF MARGIN19.52%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
+245%⤢
STOCK-BASED COMP
$0.0B
+1%⤢
CAPITAL EXPENDITURE
$0.0B
+1012%⤢
SHARES OUTSTANDING
0.03B
-24%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.5B
+3335%⤢
TOTAL DEBT
—
-64%⤢
DEBT / EBITDA (TTM)
—
-73%0.4x2.0x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 88.00%INSIDERS 19.83%OTHER / RETAIL 0.00%948 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.85% | 2.5M | $1.46B | +2.4% |
| AQR Capital Management, LLC | 4.85% | 1.4M | $799.7M | +0.3% |
| Vanguard Portfolio Management LLC | 4.02% | 1.1M | $662.5M | NEW |
| Vanguard Capital Management LLC | 3.62% | 1.0M | $597.2M | NEW |
| Geode Capital Management, LLC | 2.67% | 745K | $440.1M | +11.7% |
| State Street Corporation | 2.44% | 682K | $403.0M | +2.6% |
| Wasatch Advisors LP | 2.28% | 637K | $376.0M | -17.8% |
| Invesco Ltd. | 2.07% | 578K | $341.2M | +19.7% |
| Renaissance Technologies, LLC | 1.81% | 505K | $298.1M | +8.3% |
| BAILLIE GIFFORD & CO | 1.70% | 473K | $279.5M | -6.0% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.